XML 22 R41.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2019
Share-based Payment Arrangement [Abstract]  
Summary of the Components of Total Stock-Based Compensation Expense The following table summarizes the components of total stock-based compensation expense included in the consolidated statements of operations for the periods presented.
 
Years Ended December 31,
 
2019
 
2018
 
2017
 
(In thousands)
Cost of revenues
$
1,650

 
$
1,071

 
$
1,072

Research and development
4,897

 
2,940

 
2,573

Sales and marketing
5,678

 
3,074

 
1,157

General and administrative
7,216

 
4,347

 
1,925

Restructuring
735

 

 

Total
$
20,176

 
$
11,432

 
$
6,727


Summary of Stock-Based Compensation Associated with Each Type of Award
The following table summarizes the various types of stock-based compensation expense for the periods presented.
 
Years Ended December 31,
 
2019
 
2018
 
2017
 
(In thousands)
Stock options, RSUs, and PSUs
$
19,216

 
$
10,691

 
$
5,559

Employee stock purchase plan
960

 
741

 
1,168

Total
$
20,176

 
$
11,432

 
$
6,727


Summary of the Weighted-Average Grant Date Fair Value of Options Granted
The following table presents the weighted-average grant date fair value of options granted for the periods presented and the assumptions used to estimate those values using a Black-Scholes option pricing model.
 
Years Ended December 31,
 
2019
 
2018
 
2017
Weighted average grant date fair value
$
9.16

 
$
2.83

 
$
0.76

Expected term (in years)
3.8

 
4.0

 
4.4

Expected volatility
89.1
%
 
88.5
%
 
83.9
%
Annual risk-free rate of return
2.1
%
 
2.6
%
 
1.8
%
Dividend yield
%
 
%
 
%

Summary of Stock Option Activity
The following is a summary of stock option activity.
 
Number of
Shares
Outstanding
 
Weighted-
Average
Exercise Price
per Share
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(1)
 
(In thousands)
 
 
 
(Years)
 
(In thousands)
Outstanding at December 31, 2016
8,730

 
$
4.55

 
 
 
 
Granted
4,500

 
1.22

 
 
 
 
Exercised
(425
)
 
0.51

 
 
 
$
544

Canceled
(4,379
)
 
6.91

 
 
 
 
Outstanding at December 31, 2017
8,426

 
$
1.77

 
 
 
 
Granted
213

 
4.43

 
 
 
 
Exercised
(1,346
)
 
1.75

 
 
 
5,096

Canceled
(521
)
 
2.94

 
 
 
 
Outstanding at December 31, 2018
6,772

 
$
1.76

 
 
 
 
Granted
43

 
14.58

 
 
 
 
Exercised
(2,616
)
 
1.22

 
 
 
31,093

Canceled
(102
)
 
4.07

 
 
 
 
Outstanding at December 31, 2019
4,097

 
$
2.18

 
4.3
 
$
98,103

Vested and expected to vest at December 31, 2019
4,097

 
$
2.18

 
4.3
 
$
98,103

Exercisable at December 31, 2019
2,887

 
$
2.44

 
4.1
 
$
68,397

 
 
(1)
The intrinsic value of options exercised is based upon the value of the Company’s stock at exercise. The intrinsic value of options outstanding, vested and expected to vest, and exercisable as of December 31, 2019 is based on the closing price of the Company’s stock fair value on December 31, 2019 or the earlier of the last trading day prior to December 31, 2019, if December 31, 2019 is a non-trading day. The Company’s stock fair value used in this computation was $26.13 per share.
Summary of Stock Option Outstanding
The following table summarizes information about stock options outstanding at December 31, 2019.
 
 
Options Outstanding
 
Options Exercisable
Range of Exercise Prices
 
Number of
Shares
 
Weighted-
Average
Remaining
Life
 
Weighted-
Average
Exercise
Price
 
Number of
Shares
 
Weighted-
Average
Exercise
Price
 
 
(In thousands)
 
(Years)
 
 
 
(In thousands)
 
 
$0.64 —– $1.11
 
774

 
5.0
 
$
0.82

 
518

 
$
0.78

$1.29 —– $1.29
 
1,000

 
4.7
 
1.29

 
563

 
1.29

$1.31 —– $1.31
 
1,309

 
4.3
 
1.31

 
975

 
1.31

$1.37 —– $7.50
 
867

 
3.2
 
4.18

 
702

 
4.57

$7.68 —– $14.58
 
147

 
3.4
 
11.45

 
129

 
11.02

Total
 
4,097

 
4.3
 
$
2.18

 
2,887

 
$
2.44


Summary of Restricted Stock Unit Activity
The following is a summary of RSU activity.
 
Number of
Shares
Outstanding
 
Weighted-
Average
Fair Value
per Share at
Grant Date
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(1)
 
(In thousands)
 
 
 
(Years)
 
(In thousands)
Outstanding at December 31, 2016
606

 
$
9.33

 
 
 
 
Granted
5,418

 
1.46

 
 
 
 
Vested
(885
)
 
3.81

 
 
 
$
932

Canceled
(1,634
)
 
1.90

 
 
 
 
Outstanding at December 31, 2017
3,505

 
$
2.03

 
 
 
 
Granted
3,152

 
4.45

 
 
 
 
Vested
(1,399
)
 
2.75

 
 
 
6,657

Canceled
(906
)
 
2.17

 
 
 
 
Outstanding at December 31, 2018
4,352

 
$
3.52

 
 
 
 
Granted
2,112

 
11.50

 
 
 
 
Vested
(1,707
)
 
3.87

 
 
 
27,156

Canceled
(494
)
 
4.81

 
 
 
 
Outstanding at December 31, 2019
4,263

 
$
7.19

 
1.3
 
$
111,387

Expected to vest at December 31, 2019
4,263

 
$
7.19

 
1.3
 
$
111,387

 
 
(1)
The intrinsic value of RSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of RSUs outstanding and expected to vest as of December 31, 2019 is based on the closing price of the Company’s stock on December 31, 2019 or the earlier of the last trading day prior to December 31, 2019, if December 31, 2019 is a non-trading day. The Company’s stock fair value used in this computation was $26.13 per share.
Share-based Compensation, Performance Shares Award Outstanding Activity
The following is a summary of PSU activity.
 
Number of
Shares
Outstanding
 
Weighted-
Average
Fair Value
per Share at
Grant Date
 
Weighted-
Average
Remaining
Contractual
Term
 
Aggregate
Intrinsic
Value
(1)
 
(In thousands)
 
 
 
(Years)
 
(In thousands)
Outstanding at December 31, 2017

 

 
 
 
 
Granted
1,477

 
$
4.65

 
 
 
 
Vested

 

 
 
 

Canceled
(147
)
 

 
 
 
 
Outstanding at December 31, 2018
1,330

 
$
4.66

 
 
 
 
Granted
1,052

 
9.48

 
 
 
 
Vested
(1,063
)
 
4.62

 
 
 
$
10,818

Canceled
(364
)
 
5.16

 
 
 
 
Outstanding at December 31, 2019
955

 
$
9.83

 
0.2
 
$
24,952

 
 
(1)
The intrinsic value of PSUs vested is based upon the value of the Company’s stock when vested. The intrinsic value of PSUs outstanding and expected to vest as of December 31, 2019 is based on the closing price of the Company’s stock on December 31, 2019 or the earlier of the last trading day prior to December 31, 2019, if December 31, 2019 is a non-trading day. The Company’s stock fair value used in this computation was $26.13 per share.
Schedule of Share-based Compensation, Employee Stock Purchase Plan, Activity
A summary of ESPP activity for the years presented is as follows: (in thousands, except per share data):
 
Years Ended December 31,
 
2019
 
2018
 
2017
Proceeds from common stock issued under ESPP
$
1,692

 
$
397

 
$
313

Shares of common stock issued
315

 
439

 
478

Weighted-average price per share
$
5.37

 
$
0.90

 
$
0.65